Yissum Research Development Inks Research Deals with BSII to Develop New Materials for Solar Power Plants

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd., the technology transfer arm of the University, today announced that it had signed two research agreements with BrightSource Industries Israel (BSII) for the development of new materials for solar thermal power plants.

Under the agreement, BrightSource will fund research in the laboratories of Professors Daniel Mandler, and Shlomo Magdassi, both from the Institute of Chemistry at the Hebrew University of Jerusalem. This research collaboration is based on the knowhow of Yissum and BSII. In addition to payment of research fees, BSII will compensate Yissum upon the successful implementation of the technology in its solar power plants. Financial terms were not disclosed.

The new materials may be integrated in the solar thermal power plant technology developed by BSII and implemented in new utility-scale power plants worldwide. The BSII technology generates electric power from solar energy by using a field of mirrors to reflect sunlight onto a boiler mounted atop a central tower (LPT- Luz Power Tower), where water is converted to superheated steam that drives a turbine generator.

"Solar energy is definitely the most important, yet underutilized, clean energy source. Israel has always been a leading player in the solar energy field, and the Hebrew University is proud to collaborate with BrightSource Industries Israel in increasing the efficiency of solar thermal power plants," said Yaacov Michlin, CEO of Yissum.

Yoel Gilon, Senior Vice President of BSII, said, “BSII’s partnership with Yissum will leverage the academic and research excellence of the Hebrew University to develop cutting-edge new technologies for clean, cost-effective solar thermal power plants. The excellent level of cooperation among Yissum, the university researchers and BSII will be of great value to all the parties involved.”

Source: http://www.yissum.co.il/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.